In the News: 02/04

Celebrex Or Vioxx? It’s A Toss Up Despite some heated claims and counter-claims, selective COX-2 inhibitors celecoxib (Celebrex) and rofecoxib (Vioxx) have been found to be equally effective. This was the finding following a study by Dr. Allan Gibofsky and his colleagues at Cornell University’s Weill Medical College. The head-to-head, placebo-controlled test, reported in the November 2003 Arthritis & Rheumatism, involved 475 patients with knee osteoarthritis who were given celecoxib (200mg/day), rofecoxib (25mg/day), or a placebo.…